TFIPS
VRTX icon

Towarzystwo Funduszy Inwestycyjnych PZU SA’s Vertex Pharmaceuticals VRTX Stock Holding History

Towarzystwo Funduszy Inwestycyjnych PZU SA’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$522K Buy
1,051
+85
+9% +$37.7K 0.15% 110
2026
Q1 		$431K Sell
966
-223
-19% -$104K 0.14% 114
2025
Q4 		$539K Hold
1,189
– – 0.14% 91
2025
Q3 		$466K Sell
1,189
-805
-40% -$336K 0.11% 92
2025
Q2 		$888K Sell
1,994
-75
-4% -$34.6K 0.25% 48
2025
Q1 		$1M Sell
2,069
-516
-20% -$240K 0.34% 43
2024
Q4 		$1.04M Sell
2,585
-15
-0.6% -$6.95K 0.34% 37
2024
Q3 		$1.21M Buy
2,600
+70
+3% +$33.6K 0.44% 32
2024
Q2 		$1.19M Sell
2,530
-50
-2% -$21.7K 0.44% 32
2024
Q1 		$1.08M Buy
2,580
+60
+2% +$25.4K 0.46% 31
2023
Q4 		$1.03M Buy
+2,520
New +$931K 0.47% 31
2021
Q3 		$465K Sell
2,566
-75
-3% -$14.6K 0.56% 30
2021
Q2 		$533K Hold
2,641
– – 0.63% 27
2021
Q1 		$568K Sell
2,641
-700
-21% -$154K 0.83% 20
2020
Q4 		$790K Buy
+3,341
New +$767K 0.82% 22

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Towarzystwo Funduszy Inwestycyjnych PZU SA's VRTX Position: Q2 2026 in Review

Towarzystwo Funduszy Inwestycyjnych PZU SA increased its Vertex Pharmaceuticals (VRTX) stake by 8.8% in Q2 2026, buying an estimated $37.7K and bringing the position to 1,051 shares worth $522K. The position accounts for 0.15% of the portfolio, ranked #110.

Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in VRTX in Q4 2020 and has held it in 15 quarters since. The position peaked at $1.21M in Q3 2024. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Towarzystwo Funduszy Inwestycyjnych PZU SA held 1,051 shares of Vertex Pharmaceuticals worth $522K as of Q2 2026.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA bought 85 Vertex Pharmaceuticals shares in Q2 2026, an estimated $37.7K.
  • Vertex Pharmaceuticals made up 0.15% of Towarzystwo Funduszy Inwestycyjnych PZU SA's portfolio in Q2 2026, its #110 holding.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in Vertex Pharmaceuticals in Q4 2020 and has held it in 15 quarters since.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA's Vertex Pharmaceuticals position peaked at $1.21M in Q3 2024.
  • 1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Towarzystwo Funduszy Inwestycyjnych PZU SA's 13F filing for Q2 2026, filed 7 Aug 2026.